IUASX
Price
$43.60
Change
-$0.32 (-0.73%)
Updated
Dec 17 closing price
RIDAX
Price
$24.61
Change
-$0.13 (-0.53%)
Updated
Dec 17 closing price
Ad is loading...

IUASX vs RIDAX

Header iconIUASX vs RIDAX Comparison
Open Charts IUASX vs RIDAXBanner chart's image
VY® Invesco Equity and Income S
Price$43.60
Change-$0.32 (-0.73%)
VolumeN/A
CapitalizationN/A
American Funds Income Fund of Amer R1
Price$24.61
Change-$0.13 (-0.53%)
VolumeN/A
CapitalizationN/A
IUASX vs RIDAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IUASX vs. RIDAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IUASX is a Sell and RIDAX is a Buy.

FUNDAMENTALS
Fundamentals
RIDAX has more cash in the bank: 123B vs. IUASX (478M). RIDAX pays higher dividends than IUASX: RIDAX (2.82) vs IUASX (1.79). IUASX was incepted earlier than RIDAX: IUASX (23 years) vs RIDAX (23 years). IUASX is a more actively managed with annual turnover of: 144.00 vs. RIDAX (40.00). IUASX has a lower initial minimum investment than RIDAX: IUASX (0) vs RIDAX (250). RIDAX annual gain was more profitable for investors over the last year : 10.05 vs. IUASX (6.48). RIDAX return over 5 years is better than : 17.26 vs. IUASX (6.65).
IUASXRIDAXIUASX / RIDAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD5.5898.72164%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets478M123B0%
Annual Yield % from dividends1.792.8263%
Returns for 1 year6.4810.0564%
Returns for 3 years-11.634.51-258%
Returns for 5 years6.6517.2639%
Returns for 10 years8.9128.1132%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPK1.610.01
+0.62%
OPKO Health
PFG77.54-1.13
-1.44%
Principal Financial Group
HI30.81-0.69
-2.19%
Hillenbrand
VRA3.88-0.10
-2.51%
Vera Bradley
BTAI0.39-0.02
-4.01%
BioXcel Therapeutics